Literature DB >> 31401712

Losartan accelerates the repair process of renal fibrosis in UUO mouse after the surgical recanalization by upregulating the expression of Tregs.

Jie Song1, Yangyang Xia2, Xiang Yan3,4, Jia Luo2, Chunming Jiang2, Miao Zhang1,2, Guo-Ping Shi4, Wei Zhu5,6.   

Abstract

Obstructive nephropathy is a common cause for chronic kidney disease. Surgery, which is adopted to promptly relieve the obstruction, is the most important method to save damaged kidneys. However, earlier studies have shown that renal function will continue to deteriorate until the terminal stage after the obstruction' relief. The aim of this study is to explore the renal fibrosis and investigate the effect of losartan on renal fibrosis after the obstruction' relief using an improved mouse model of relief for unilateral ureteral obstruction (RUUO). Experiments carried out using C57BL/6 mice (n = 30) were randomly divided into RUUO + Losartan group, RUUO group and sham group. Using an improved mouse RUUO model, this study revealed that the mouse kidney for 3- or 7-day unilateral ureteral obstruction undergoing the RUUO surgery was still in a state of injury and fibrosis, while losartan could effectively ameliorate renal fibrosis by upregulating the expression of CD4 + CD25 + Foxp3 + regulatory T cells (Tregs) in kidney after the surgery of RUUO.

Entities:  

Keywords:  Losartan; Mouse model; RUUO; Renal fibrosis; Tregs

Mesh:

Substances:

Year:  2019        PMID: 31401712     DOI: 10.1007/s11255-019-02253-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  34 in total

Review 1.  Angiotensin II, TGF-beta and renal fibrosis.

Authors:  J Gaedeke; H Peters; N A Noble; W A Border
Journal:  Contrib Nephrol       Date:  2001       Impact factor: 1.580

Review 2.  Obstructive nephropathy: towards biomarker discovery and gene therapy.

Authors:  Robert L Chevalier
Journal:  Nat Clin Pract Nephrol       Date:  2006-03

3.  Effect of unilateral ureteral obstruction and anti-angiotensin II treatment on renal tubule cell apoptosis and interstitial fibrosis in rats.

Authors:  Nikola Radović; Gorana Aralica; Danica Galesić Ljubanović; Vjekoslav Jelec; Mladen Kontek
Journal:  Coll Antropol       Date:  2014-06

4.  Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation.

Authors:  Johannes Weirather; Ulrich D W Hofmann; Niklas Beyersdorf; Gustavo C Ramos; Benjamin Vogel; Anna Frey; Georg Ertl; Thomas Kerkau; Stefan Frantz
Journal:  Circ Res       Date:  2014-04-30       Impact factor: 17.367

Review 5.  Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis.

Authors:  W A Border; N A Noble
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

6.  Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney.

Authors:  Gilbert R Kinsey; Liping Huang; Amy L Vergis; Li Li; Mark D Okusa
Journal:  Kidney Int       Date:  2010-02-17       Impact factor: 10.612

Review 7.  TGF-beta signaling in renal disease.

Authors:  Erwin P Böttinger; Markus Bitzer
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

Review 8.  Fibroblast activation and myofibroblast generation in obstructive nephropathy.

Authors:  María T Grande; José M López-Novoa
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314

Review 9.  Cytokines in epithelial-mesenchymal transition: a new insight into obstructive nephropathy.

Authors:  Ahmad H Bani-Hani; Matthew T Campbell; Daniel R Meldrum; Kirstan K Meldrum
Journal:  J Urol       Date:  2008-06-11       Impact factor: 7.450

10.  Protective Effect of CXCR3⁺CD4⁺CD25⁺Foxp3⁺ Regulatory T Cells in Renal Ischemia-Reperfusion Injury.

Authors:  Cao Jun; Li Qingshu; Wei Ke; Li Ping; Dong Jun; Luo Jie; Min Su
Journal:  Mediators Inflamm       Date:  2015-07-27       Impact factor: 4.711

View more
  1 in total

1.  Tengdan Capsule Prevents Hypertensive Kidney Damage in SHR by Inhibiting Periostin-Mediated Renal Fibrosis.

Authors:  Xiaoli Du; Qianqian Tao; Hongxia Du; Zhenbang Zhao; Yu Dong; Shuang He; Rui Shao; Yule Wang; Wenrun Han; Xintong Wang; Yan Zhu
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.